{rfName}
Es

Project information

ID: 2-55-52030-729

Fecha inicio

16-09-2009

Fecha fin

N/A


Institutional Coordinator
Institut Català d'Oncologia (ICO)

Financing

350,00 Euros
(Total amount or amount awarded)

More information in

Analysis of institutional authors

Teule Vega, AlexandrePrincipal investigator

Share

November 5, 2012
Clinical Trials
>
Clinical Trial
No

Estudio abierto, de extensión, con Lanreotida autogel 120 mg en pacientes con tumor endocrino entero-pancreático no funcional.

Researchers: Teule Vega, Alexandre (Investigador principal (IP))

Affiliations

ICO. Unitat De Consell Genètic (Ucg) (Program)

Abstract


Keywords

Financing

Quality index

Financer

Ipsen Pharma; IPSEN PHARMA, S.A.

N. of Participants

90 (Final patients)

Institutional Coordinator

Si

Related items